These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

601 related items for PubMed ID: 30905239

  • 1. Ursolic acid inhibits epithelial-mesenchymal transition in vitro and in vivo.
    Xu CG, Zhu XL, Wang W, Zhou XJ.
    Pharm Biol; 2019 Dec; 57(1):169-175. PubMed ID: 30905239
    [Abstract] [Full Text] [Related]

  • 2. Pirfenidone suppresses MAPK signalling pathway to reverse epithelial-mesenchymal transition and renal fibrosis.
    Li Z, Liu X, Wang B, Nie Y, Wen J, Wang Q, Gu C.
    Nephrology (Carlton); 2017 Aug; 22(8):589-597. PubMed ID: 27245114
    [Abstract] [Full Text] [Related]

  • 3. Alpha1-Antitrypsin Attenuates Renal Fibrosis by Inhibiting TGF-β1-Induced Epithelial Mesenchymal Transition.
    Cho JH, Ryu HM, Oh EJ, Yook JM, Ahn JS, Jung HY, Choi JY, Park SH, Kim YL, Kwak IS, Kim CD.
    PLoS One; 2016 Aug; 11(9):e0162186. PubMed ID: 27607429
    [Abstract] [Full Text] [Related]

  • 4. [Modified Fangji Huangqi Decoction alleviates renal interstitial fibrosis by inhibiting TGF-β1/Smad/Snail signaling pathway during epithelial-mesenchymal transition].
    Deng YW, Jin L, Chen DP.
    Zhongguo Zhong Yao Za Zhi; 2024 Jun; 49(11):3012-3020. PubMed ID: 39041161
    [Abstract] [Full Text] [Related]

  • 5. Hydroxysafflor Yellow A Ameliorates Renal Fibrosis by Suppressing TGF-β1-Induced Epithelial-to-Mesenchymal Transition.
    Hu N, Duan J, Li H, Wang Y, Wang F, Chu J, Sun J, Liu M, Wang C, Lu C, Wen A.
    PLoS One; 2016 Jun; 11(4):e0153409. PubMed ID: 27088510
    [Abstract] [Full Text] [Related]

  • 6. Salidroside Ameliorates Renal Interstitial Fibrosis by Inhibiting the TLR4/NF-κB and MAPK Signaling Pathways.
    Li R, Guo Y, Zhang Y, Zhang X, Zhu L, Yan T.
    Int J Mol Sci; 2019 Mar 04; 20(5):. PubMed ID: 30836660
    [Abstract] [Full Text] [Related]

  • 7. Total flavonoids from Smilax glabra Roxb blocks epithelial-mesenchymal transition and inhibits renal interstitial fibrosis by targeting miR-21/PTEN signaling.
    Luo Q, Cai Z, Tu J, Ling Y, Wang D, Cai Y.
    J Cell Biochem; 2019 Mar 04; 120(3):3861-3873. PubMed ID: 30304552
    [Abstract] [Full Text] [Related]

  • 8. Autophagy attenuates renal fibrosis in obstructive nephropathy through inhibiting epithelial-to-mesenchymal transition.
    Zhang B, Ru F, Chen X, Chen Z.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2021 Jun 28; 46(6):601-608. PubMed ID: 34275928
    [Abstract] [Full Text] [Related]

  • 9. [Role of protein phosphatase 2A in renal interstitial fibrosis].
    Xi Y, Li H, Li J, Li Y, Liu Y, You Y, Duan S, Liu H, Sun L, Peng Y, Liu F.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2015 Jun 28; 40(6):569-78. PubMed ID: 26164503
    [Abstract] [Full Text] [Related]

  • 10. HSP27 is involved in the pathogenesis of kidney tubulointerstitial fibrosis.
    Vidyasagar A, Reese S, Acun Z, Hullett D, Djamali A.
    Am J Physiol Renal Physiol; 2008 Sep 28; 295(3):F707-16. PubMed ID: 18596079
    [Abstract] [Full Text] [Related]

  • 11. The selective A3AR antagonist LJ-1888 ameliorates UUO-induced tubulointerstitial fibrosis.
    Lee J, Hwang I, Lee JH, Lee HW, Jeong LS, Ha H.
    Am J Pathol; 2013 Nov 28; 183(5):1488-1497. PubMed ID: 24001475
    [Abstract] [Full Text] [Related]

  • 12. Sorafenib ameliorates renal fibrosis through inhibition of TGF-β-induced epithelial-mesenchymal transition.
    Jia L, Ma X, Gui B, Ge H, Wang L, Ou Y, Tian L, Chen Z, Duan Z, Han J, Fu R.
    PLoS One; 2015 Nov 28; 10(2):e0117757. PubMed ID: 25679376
    [Abstract] [Full Text] [Related]

  • 13. The glucagon-like peptide-1 (GLP-1) analog liraglutide attenuates renal fibrosis.
    Li YK, Ma DX, Wang ZM, Hu XF, Li SL, Tian HZ, Wang MJ, Shu YW, Yang J.
    Pharmacol Res; 2018 May 28; 131():102-111. PubMed ID: 29530599
    [Abstract] [Full Text] [Related]

  • 14. The regulatory peptide apelin: a novel inhibitor of renal interstitial fibrosis.
    Wang LY, Diao ZL, Zhang DL, Zheng JF, Zhang QD, Ding JX, Liu WH.
    Amino Acids; 2014 Dec 28; 46(12):2693-704. PubMed ID: 25164121
    [Abstract] [Full Text] [Related]

  • 15. Novel RAS inhibitor 25-O-methylalisol F attenuates epithelial-to-mesenchymal transition and tubulo-interstitial fibrosis by selectively inhibiting TGF-β-mediated Smad3 phosphorylation.
    Chen H, Yang T, Wang MC, Chen DQ, Yang Y, Zhao YY.
    Phytomedicine; 2018 Mar 15; 42():207-218. PubMed ID: 29655688
    [Abstract] [Full Text] [Related]

  • 16. Renalase Protects against Renal Fibrosis by Inhibiting the Activation of the ERK Signaling Pathways.
    Wu Y, Wang L, Deng D, Zhang Q, Liu W.
    Int J Mol Sci; 2017 Apr 27; 18(5):. PubMed ID: 28448446
    [Abstract] [Full Text] [Related]

  • 17. Alleviation of TGF-β1 induced tubular epithelial-mesenchymal transition via the δ-opioid receptor.
    Luo F, Xu R, Song G, Xue D, He X, Xia Y.
    FEBS J; 2021 Feb 27; 288(4):1243-1258. PubMed ID: 32563195
    [Abstract] [Full Text] [Related]

  • 18. Anti-renal fibrosis effect of asperulosidic acid via TGF-β1/smad2/smad3 and NF-κB signaling pathways in a rat model of unilateral ureteral obstruction.
    Xianyuan L, Wei Z, Yaqian D, Dan Z, Xueli T, Zhanglu D, Guanyi L, Lan T, Menghua L.
    Phytomedicine; 2019 Feb 27; 53():274-285. PubMed ID: 30668407
    [Abstract] [Full Text] [Related]

  • 19. Nrf2 signaling attenuates epithelial-to-mesenchymal transition and renal interstitial fibrosis via PI3K/Akt signaling pathways.
    Wang J, Zhu H, Huang L, Zhu X, Sha J, Li G, Ma G, Zhang W, Gu M, Guo Y.
    Exp Mol Pathol; 2019 Dec 27; 111():104296. PubMed ID: 31449784
    [Abstract] [Full Text] [Related]

  • 20. V-ATPase promotes transforming growth factor-β-induced epithelial-mesenchymal transition of rat proximal tubular epithelial cells.
    Cao X, Yang Q, Qin J, Zhao S, Li X, Fan J, Chen W, Zhou Y, Mao H, Yu X.
    Am J Physiol Renal Physiol; 2012 May 01; 302(9):F1121-32. PubMed ID: 22129967
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.